BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Does probiotics administration decrease serum endotoxin levels in infants? ✅
Journal of pediatric surgery (J Pediatr Surg ) Vol: 34 Issue 2 Pages: 273-6 Pub: 1999 Feb Epub: Authors Urao M , Fujimoto T , Lane GJ , Seo G , Miyano T , |
|
|
Probiotic Therapy (BIO-THREE) Mitigates Intestinal Microbial Imbalance and Intestinal Damage Caused by Oxaliplatin. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 14 Issue 1 Pages: 60-71 Pub: 2022 Feb Epub: 2021 May 6 Authors Yuan W , Xiao X , Yu X , Xie F , Feng P , Malik K , Wu J , Ye Z , Zhang P , Li X , |
|
|
The Effect of Clostridium butyricum on Gut Microbial Changes and Functional Profiles of Metabolism in High-fat Diet-fed Rats Depending on Age and Sex. ✅
Go to Publication ✅
Journal of neurogastroenterology and motility (J Neurogastroenterol Motil ) Vol: 30 Issue 2 Pages: 236-250 Pub: 2024 Apr 30 Epub: Authors Choi SI , Kim N , Choi Y , Nam RH , Jang JY , Cho SY , |
|
|
The Effect of Clostridium butyricum on Gut Microbial Changes and Functional Profiles of Metabolism in High-fat Diet-fed Rats Depending on Age and Sex. ✅
Go to Publication ✅
Journal of neurogastroenterology and motility (J Neurogastroenterol Motil ) Vol: 30 Issue 2 Pages: 236-250 Pub: 2024 Apr 30 Epub: Authors Choi SI , Kim N , Choi Y , Nam RH , Jang JY , Cho SY , |
|
|
The antioxidant strain Lactiplantibacillus plantarum AS21 and Clostridium butyricum ameliorate DSS-induced colitis in mice by remodeling the assembly of intestinal microbiota and improving gut functions. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 4 Pages: 2022-2037 Pub: 2024 Feb 19 Epub: 2024 Feb 19 Authors Li W , Zhang Y , Chen M , Guo X , Ding Z , |
|
|
Effects of compatibility of Clostridium butyricum and Bacillus subtilis on growth performance, lipid metabolism, antioxidant status and cecal microflora of broilers during the starter phase. ✅
Go to Publication ✅
Animal bioscience (Anim Biosci ) Vol: 37 Issue 11 Pages: 1933-1944 Pub: 2024 Nov Epub: 2024 Jun 27 Authors Zhao X , Zhuang J , Zhang F , Li H , Yu J , Wang C , Lv T , Li Q , Zhang J , |
|
|
Maternal Clostridium butyricum supplementation during late gestation and lactation enhances gut bacterial communities, milk quality, and reduces piglet diarrhea. ✅
Go to Publication ✅
Computational and structural biotechnology journal (Comput Struct Biotechnol J ) Vol: 27 Issue Pages: 2933-2945 Pub: 2025 Epub: 2025 Jun 25 Authors Nuntapaitoon M , Chatthanathon P , Palasuk M , Wilantho A , Ruampatana J , Tongsima S , Settachaimongkon S , Somboonna N , |
|
|
Maternal Clostridium butyricum supplementation during late gestation and lactation enhances gut bacterial communities, milk quality, and reduces piglet diarrhea. ✅
Go to Publication ✅
Computational and structural biotechnology journal (Comput Struct Biotechnol J ) Vol: 27 Issue Pages: 2933-2945 Pub: 2025 Epub: 2025 Jun 25 Authors Nuntapaitoon M , Chatthanathon P , Palasuk M , Wilantho A , Ruampatana J , Tongsima S , Settachaimongkon S , Somboonna N , |
|
|
Clostridium butyricum Supplementation Reduces Diarrhea in Preweaning Calves by Modulating Fecal Short-Chain Fatty Acids and Gut Microbiota. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 13 Issue 9 Pages: Pub: 2025 Aug 27 Epub: 2025 Aug 27 Authors Gao P , Pang S , Wang Q , Tang Y , Li Q , Zhang W , Nie C , Ma X , Niu J , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
